Combined prophylactic and therapeutic immune responses against human papillomaviruses induced by a thioredoxin-based L2-E7 nanoparticle vaccine

Global burden of cervical cancer, the most common cause of mortality caused by human papillomavirus (HPV), is expected to increase during the next decade, mainly because current alternatives for HPV vaccination and cervical cancer screening programs are costly to be established in low-and-middle inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xueer, Yang, Fan, Mariz, Filipe, Osen, Wolfram, Bolchi, Angelo, Ottonello, Simone, Müller, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498061/
https://www.ncbi.nlm.nih.gov/pubmed/32886721
http://dx.doi.org/10.1371/journal.ppat.1008827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498061/
https://www.ncbi.nlm.nih.gov/pubmed/32886721
http://dx.doi.org/10.1371/journal.ppat.1008827

Ejemplares similares